Delivery Order SPE2DB20D2104-SPE2DB25FMVJM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of EUCRISA 2% Ointment in 60-gram units under a firm fixed-price contract with a ceiling value of $4,106.07. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of EUCRISA 2% ointment (60 gram tubes), a topical treatment for a skin condition. The contract has a ceiling value of $1,216.56 and a completion date of January 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a $3,768.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUCRISA 2% ointment, a dermatological product, to support military healthcare programs. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,788.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of EUCRISA 2% ointment, a prescription medication, with a period of performance through August 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the procurement of a...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $796 to Amerisourcebergen Drug Corporation for EUCRISA 2% ointment. The contract calls for Amerisourcebergen to deliver 60 grams of EUCRISA to a location in Conshohocken, Pennsylvania. EUCRISA is a topical medication used to treat plaque psoriasis. The delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,808.20 firm-fixed-price contract is for the supply of EUCRISA 2% ointment, a pharmaceutical product, with an ultimate completion date of August 17, 2023. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. The company is a major supplier of pharmaceutical products and medical supplies to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of EUCRISA 2% ointment, a specialty pharmaceutical product, with a ceiling value of $1,554.51 and an ultimate completion date of January 14, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $7,963.75, and an ultimate completion date of July 26, 2024. The award covers the procurement of EUCRISA 2% Ointment 60GM, a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency Troop Support Medical awarded a $904.12 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 60 grams of EUCRISA 2% ointment. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 25-26, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Defense Logistics Agency's medical supply...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of EUCRISA 2% ointment 60GM. The contract has a ceiling value of $2,913.85 and a period of performance through April 8, 2025. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVJMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,790.85 to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment (60 gm) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. EUCRISA is a topical calcineurin inhibitor commonly used to treat atopic dermatitis and other inflammatory skin conditions, representing a specialized pharmaceutical product within the company's broader medical supply portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The parent IDC enables the company to fulfill diverse medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/14/25 |